(Q34562841)

3 August 2017

Outcome and survival of asymptomatic PML in natalizumab-treated MS patients (English)

1 reference

3 August 2017

0 references

Tuan Dong-Si

1

1 reference

3 August 2017

Sandra Richman

2

1 reference

3 August 2017

Mike P Wattjes

3

1 reference

3 August 2017

Made Wenten

4

1 reference

3 August 2017

Sarah Gheuens

5

1 reference

3 August 2017

Jeffrey Philip

6

1 reference

3 August 2017

Shoibal Datta

7

1 reference

3 August 2017

James McIninch

8

1 reference

3 August 2017

Carmen Bozic

9

1 reference

3 August 2017

Gary Bloomgren

10

1 reference

3 August 2017

Nancy Richert

11

1 reference

3 August 2017

9 October 2014

1 reference

Annals of clinical and translational neurology

3 August 2017

1 reference

3 August 2017

1

1 reference

3 August 2017

10

1 reference

3 August 2017

755-764

1 reference

The chameleon of neuroinflammation: magnetic resonance imaging characteristics of natalizumab-associated progressive multifocal leukoencephalopathy

3 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241803

Disease course and outcome of 15 monocentrically treated natalizumab-associated progressive multifocal leukoencephalopathy patients

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241803

PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241803

Early magnetic resonance detection of natalizumab-related progressive multifocal leukoencephalopathy in a patient with multiple sclerosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241803

Presymptomatic diagnosis with MRI and adequate treatment ameliorate the outcome after natalizumab-associated progressive multifocal leukoencephalopathy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241803

Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241803

JC virus detection and JC virus-specific immunity in natalizumab-treated multiple sclerosis patients

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241803

Natalizumab: bench to bedside and beyond

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241803

Risk of natalizumab-associated progressive multifocal leukoencephalopathy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241803

Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241803

Progressive multifocal leukoencephalopathy and other forms of JC virus disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241803

Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241803

Progressive multifocal leukoencephalopathy in HIV-1 infection

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241803

Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241803

Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241803

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241803

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241803

Clinically silent PML and prolonged immune reconstitution inflammatory syndrome in a patient with multiple sclerosis treated with natalizumab.

7 July 2018

1 reference

Progressive multifocal leukoencephalopathy after natalizumab monotherapy.

21 January 2018

1 reference

Asymptomatic progressive multifocal leukoencephalopathy associated with natalizumab.

21 January 2018

1 reference

The earlier, the smaller, the better for natalizumab-associated PML: in MRI vigilance veritas?

21 January 2018

1 reference

Symbolic Description of Factorial Models for Analysis of Variance

21 January 2018

1 reference

LOWESS: A Program for Smoothing Scatterplots by Robust Locally Weighted Regression

21 January 2018

1 reference

Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients.

21 January 2018

1 reference

Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome

21 January 2018

1 reference

MRI preclinical detection and asymptomatic course of a progressive multifocal leucoencephalopathy (PML) under natalizumab therapy.

21 January 2018

1 reference

Natalizumab-associated PML identified in the presymptomatic phase using MRI surveillance

21 January 2018

1 reference

12 December 2020

Indolent course of progressive multifocal leukoencephalopathy during natalizumab treatment in MS

1 reference

12 December 2020

Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy

1 reference

12 December 2020

Value of MRI as a surrogate marker for PML in natalizumab long-term therapy

1 reference

12 December 2020

Identifiers

DOI

10.1002/ACN3.114

1 reference

3 August 2017

1 reference

3 August 2017

1 reference